Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Compliance with antipsychotic treatment
Autore:
Oehl, M; Hummer, M; Fleischhacker, WW;
Indirizzi:
Innsbruck Univ Clin, Dept Biol Psychiat, A-6020 Innsbruck, Austria Innsbruck Univ Clin Innsbruck Austria A-6020 , A-6020 Innsbruck, Austria
Titolo Testata:
ACTA PSYCHIATRICA SCANDINAVICA
, volume: 102, anno: 2000, supplemento:, 407
pagine: 83 - 86
SICI:
0001-690X(2000)102:<83:CWAT>2.0.ZU;2-O
Fonte:
ISI
Lingua:
ENG
Soggetto:
MEDICATION NONCOMPLIANCE; SUBSTANCE-ABUSE; SCHIZOPHRENIA; REHOSPITALIZATION; THERAPY;
Keywords:
compliance; antipsychotic drugs; side effects; psychological factors;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Social & Behavioral Sciences
Clinical Medicine
Life Sciences
Citazioni:
25
Recensione:
Indirizzi per estratti:
Indirizzo: Oehl, M Innsbruck Univ Clin, Dept Biol Psychiat, Anichstr 35, A-6020 Innsbruck, Austria Innsbruck Univ Clin Anichstr 35 Innsbruck Austria A-6020 Austria
Citazione:
M. Oehl et al., "Compliance with antipsychotic treatment", ACT PSYC SC, 102, 2000, pp. 83-86

Abstract

Objective: Despite the demonstrated efficacy of antipsychotics the relapserate among patients with schizophrenia remains high. One major reason for this is non-compliance. Tn this article we review different factors influencing compliance and discuss possibilities to enhance compliance among schizophrenic patients. Method: This review is based on a systematic literature search in Medline. Results: We summarize the four main factors (patient-, environment-, physician- and treatment-related) that influence compliance and discuss possiblemeasures to enhance compliance. Next to many other variables discussed in more detail, it is crucial to ensure a positive doctor-patient relationshipand to provide sufficient information about the benefit/risk ratio of the medication as well as about the illness itself to build up and sustain compliance. Significant others should be included into the therapeutic alliancewhenever possible. Conclusion: Despite many published reports on compliance, it remains to bea problem of eminent clinical relevance. Clinicians must not underestimateit in order to optimize the treatment of patients with schizophrenia.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/04/20 alle ore 19:06:10